Investment Rating - The report assigns a positive investment rating to Shanghai Jahwa, indicating an expectation of outperforming the market in the next 12-18 months [19]. Core Insights - Shanghai Jahwa has demonstrated significant financial performance in 2025, with a revenue increase of 10.83% year-on-year to RMB 4.961 billion for the first nine months, and a notable 28.29% increase in Q3 revenue to RMB 1.483 billion [7][8]. - The company's gross profit margin improved to 62.81% for the first nine months, up 3.39 percentage points year-on-year, with Q3 gross margin reaching 61.48%, a substantial increase of 6.99 percentage points [7][8]. - Net profit surged by 149.12% year-on-year to RMB 405 million for the first nine months, with a net profit margin of 8.17% [7][8]. Revenue and Profit Growth - The strong growth in revenue and profit is primarily attributed to the cosmetics segment, which saw a remarkable 272% year-on-year growth, driven by a clear hero product strategy and effective new product launches [2][8]. - The personal care, cosmetics, innovation, and overseas divisions reported revenues of RMB 606 million, RMB 354 million, RMB 158 million, and RMB 365 million respectively in Q3, with cosmetics leading the growth [2][8]. Product Strategy and Market Position - The company focused on developing blockbuster products such as Herborist White Clay Mask and Dr. Yu Barrier Repair Cream, which have significantly contributed to sales and customer acquisition [2][8]. - New product launches, including Herborist Immortal Grass Oil, have quickly gained market traction, positioning them as key growth drivers for the future [3][9]. Future Outlook - Shanghai Jahwa aims to maintain a double-digit revenue growth trend and is confident in achieving a turnaround in operating profit for the full year [11]. - The company expects further gross margin improvement of 3-5 percentage points, driven by new product contributions and ongoing cost efficiencies [11]. - Specific business targets include achieving RMB 100 million GMV for Herborist Immortal Grass Oil and Dr. Yu Body Lotion by 2026, with a strategic goal of over 20% revenue growth [11].

Investment Rating - The report suggests a positive outlook on the nuclear power sector, particularly focusing on small modular reactors (SMRs) as a key energy solution for AI data centers, driven by recent administrative actions from the Trump administration [5][48][50]. Core Insights - The collaboration between OpenAI, Oracle, and Vantage Data Centers to build the "Lighthouse" Stargate data center cluster in Wisconsin is a significant development, contributing to the expansion of IT capacity in the U.S. [1][12]. - The U.S. grid reliability is under threat, with warnings from NERC about a potential "five-alarm fire" risk, indicating urgent infrastructure needs [1][26]. - The demand for gas turbines is expected to grow, driven by the re-industrialization and development of AI data centers, despite a stable electricity demand in the U.S. [18][22]. - The report highlights a robust growth in the transformer export market, particularly from China and South Korea, indicating a strong demand for electrical equipment [38][39]. Summary by Sections Global Infrastructure and Construction Equipment - North America's data center vacancy rates have reached a historic low of 1.6%, reflecting strong demand [8]. - The average price for 250 to 500 kW cabinets has increased by 2.5%, while those over 10 MW have surged by 19% due to limited power supply and rising construction costs [8]. Global Electrical and Intelligent Equipment - The gas turbine price index increased by 3.43% year-on-year as of August 2025, indicating a stable competitive landscape [15]. - The U.S. electrical transformer production price index remained stable at 440.55, with a year-on-year increase of 2.5% [29]. Global Energy Industry - The average spot price of electricity in major U.S. regions rose by 21.32% week-on-week, with a significant increase in clean energy installations [3]. - The collaboration between Oklo and Newcleo to develop advanced fuel manufacturing infrastructure in the U.S. is a notable advancement in the nuclear sector [3]. Global New Materials - The global uranium spot price increased by 10% month-on-month, reflecting a tightening supply [4]. - The price index for steel pipes and stainless steel rose by 0.58% month-on-month, indicating a positive trend in the materials market [4]. Key Company Insights and Commentary - GE Vernova is expanding its capabilities in the nuclear sector, with a focus on high-voltage equipment and small modular reactors [43]. - Siemens Energy is actively investing in expanding its transformer manufacturing capacity in Germany, indicating strong order reserves [43]. - ABB has signed significant contracts for electrification projects, showcasing its commitment to energy management solutions [41].

Investment Rating - The report assigns an "Outperform" rating to the company [1][3][10] Core Insights - In Q3 2025, the company experienced an increase in revenue year-on-year, but net profit attributable to shareholders declined significantly. The company maintained a leading sales scale in the industry despite a decrease in contracted sales and area [3][10] - The operating cash flow was strong, with a net cash flow from operating activities of RMB 68.77 billion. The asset/liability ratio continued to decrease, indicating improved financial health [3][10] - The expected EPS for 2025 is RMB 0.23, with a target price set at RMB 10.04 based on a 0.6x PB valuation [3][10] Financial Summary - For the first three quarters of 2025, the company reported revenue of RMB 1737.22 billion, a decrease of 4.95% year-on-year. In Q3 alone, revenue was RMB 568.6 billion, an increase of 30.65% year-on-year [3][10] - The net profit attributable to shareholders for the first three quarters was RMB 19.29 billion, down 75.31% year-on-year, with Q3 showing a net profit of RMB -7.82 billion, a decline of 299.19% year-on-year [3][10] - The company achieved a sales recovery of RMB 1941 billion with a recovery rate of 96%, and the cash balance at the end of the period was RMB 1226.46 billion [3][10] Sales and Construction Activity - Contracted sales for the first three quarters were RMB 2017.31 billion, down 16.53% year-on-year, with a contracted area of 1010.42 million square meters, down 25.13% year-on-year [3][10] - New construction area was 512 million square meters, a decrease of 40.19% year-on-year, while completed area was 1812 million square meters, down 12.12% year-on-year [3][10] - As of the end of Q3, the company had 549 projects under construction, with a total area of 4483 million square meters [3][10]

Investment Rating - The report maintains an "Outperform" rating for the company, expecting a relative benchmark index increase of over 10% in the next 12-18 months [20]. Core Insights - The company has raised its full-year performance guidance, anticipating ongoing business revenue growth to shift from 13-17% to 17-18% [4][8]. - As of September 2025, the company's ongoing business orders reached RMB 59.88 billion, reflecting a year-on-year increase of 41.2% [4][8]. - Revenue forecasts for 2025-2027 are projected at RMB 44.02 billion, RMB 48.85 billion, and RMB 55.90 billion, with growth rates of 12.2%, 11.0%, and 14.0% respectively [4][8]. - Net profit attributable to shareholders is expected to be RMB 16.19 billion, RMB 14.68 billion, and RMB 16.88 billion for the same period, with growth rates of 71.3%, -9.3%, and 15.0% respectively [4][8]. - The company’s EPS is projected at RMB 5.42, RMB 4.92, and RMB 5.66 for 2025-2027 [4][8]. Financial Summary - The total revenue for 2023 is reported at RMB 40.34 billion, with a slight increase of 2.5% [3]. - The net profit for 2023 is RMB 9.61 billion, showing a growth of 9.0% [3]. - The company’s net asset return rate is expected to be 21.3% in 2025, with a PE ratio of 19.14 [3][4]. - The small molecule CDMO business reported revenue of RMB 14.24 billion in the first three quarters of 2025, a year-on-year increase of 14.1% [4][8]. - The TIDES business experienced significant growth, with revenue reaching RMB 7.84 billion, up 121.1% year-on-year [4][8]. Business Developments - The company has completed the capacity expansion for polypeptides, with solid-phase synthesis reactors exceeding 100,000L by September 2025 [4][8]. - An agreement was reached to sell 100% of its China clinical service research business for RMB 2.8 billion, while maintaining stable growth in its biological business [4][8]. - The laboratory analysis and testing revenue was RMB 2.96 billion, reflecting a 2.7% year-on-year increase [4][8].

Market Performance - Global equity markets experienced a broad rally, with MSCI Global up by 1.9%, MSCI Developed Markets also up by 1.9%, and MSCI Emerging Markets rising by 2.2% [4][8] - Among developed markets, the South Korean Composite Index showed the strongest performance with a gain of 5.1%, while the Australian S&P 200 had the weakest performance with a gain of only 0.3% [8] - In emerging markets, the ChiNext Index performed best with an increase of 8.0%, while the Mexican MXX Index was the worst performer, declining by 1.0% [8] Trading Sentiment - Overall trading volume decreased across global markets, with the VIX index showing a rapid decline [19] - In terms of investor sentiment, the short-selling ratio in Hong Kong stocks decreased to 15.8%, indicating a historical low sentiment level, while the North American sentiment index rose to 90.4%, reflecting a high sentiment level [19][26] Earnings Expectations - The earnings expectations for the US tech sector were revised upward during the earnings season, with the S&P 500's EPS forecast for 2025 adjusted from 268 to 269 [63] - The Hong Kong market also saw an upward revision in earnings expectations, with the Hang Seng Index's EPS forecast for 2025 increased from 2059 to 2061 [63] - In contrast, the European market's earnings expectations remained flat, with the STOXX50 Index's EPS forecast for 2025 unchanged at 332 [64] Economic Outlook - Major market economic sentiment indicators showed improvement, with the Citigroup Economic Surprise Index for the US, Europe, and China all rising [4][63] - The rise in these indices was attributed to factors such as the potential end of the US government shutdown, easing inflation expectations, and improved US-China negotiations [4] Fund Flows - The market is increasingly pricing in two rate cuts by the Federal Reserve within the year, with expectations confirmed by recent economic data [46][50] - In terms of liquidity, there was a notable inflow of funds into the US, China, India, Japan, and South Korea, with a total inflow of 210 billion USD into these markets in September [55][58]

Market Performance - Southeast Asia ETF rose by 4.74%, with Indonesia outperforming by 0.98 percentage points[2] - Vietnam was the only market to decline, with a drop of 2.62% in the Global X MSCI Vietnam ETF, underperforming by 7.36 percentage points[3] - The Southeast Asia ETF underperformed China but outperformed the U.S., Japan, India, Africa, the U.K., and Latin America[2] Country-Specific Insights - iShares MSCI Indonesia ETF increased by 5.72%, supported by resilient fundamentals and a shift towards proactive economic stimulus[3] - iShares MSCI Singapore ETF rose slightly by 0.11%, underperforming by 4.63 percentage points, with plans for new measures to support listed companies[3] - iShares MSCI Thailand ETF gained 4.84%, bolstered by government policy initiatives and a THB 1.56 trillion investment budget for FY2026[3] - iShares MSCI Malaysia ETF increased by 1.42%, while the market experienced slight fluctuations due to local investment announcements from Microsoft and Google[3] - The sharp correction in Vietnam's stock market was attributed to bond market risks and profit-taking pressures[3] Trading Volume and Liquidity - Global X FTSE Southeast Asia ETF had a trading volume of 276,000 shares, reflecting a 3.1% increase[16] - iShares MSCI Indonesia ETF saw a trading volume of 9.36 million shares, up by 22.2%[17] - iShares MSCI Thailand ETF's trading volume decreased by 17.8%, indicating a decline in market activity[16]

Investment Rating - The report assigns a rating of "Outperform" for the company, indicating an expected total return over the next 12-18 months that exceeds the return of its relevant broad market benchmark [20]. Core Insights - The company reported a slight year-on-year decline in revenue for the first nine months of 2025, with total operating revenue of RMB 4.50 billion, down 5.4% year-on-year, and a significant drop in net profit attributable to owners, which fell by 73.2% to RMB 170 million [2][8]. - The gross profit margin for the first nine months was 21.9%, contracting by 8.3 percentage points year-on-year, but the gross margin for 3Q25 showed a sequential improvement to 24.5% [2][9]. - The company has set a clear revenue growth target of 10%-15% for the new fiscal year, with specific growth targets for sunflower seeds and nuts [4][11]. Financial Performance Summary - For the first nine months of 2025, the company achieved total operating revenue of RMB 4.50 billion, a decrease of 5.4% year-on-year, and a net profit attributable to owners of RMB 170 million, down 73.2% year-on-year [2][8]. - The gross profit margin for the first nine months was 21.9%, down 8.3 percentage points year-on-year, while the gross margin for 3Q25 was 24.5%, showing a sequential increase [2][9]. - The effective tax rate for the first nine months was 26.6%, up from 21.2% in the prior year period [2][8]. Revenue Structure and Product Performance - In 3Q25, the revenue from the sunflower seed business declined due to proactive control of sales, while the nut business grew by approximately 10%-20%, benefiting from strong performance during the Mid-Autumn Festival [3][9]. - The management indicated that the gross margin for nuts decreased by over 10 percentage points year-on-year, primarily due to rising prices of key raw materials [3][9]. Raw Material Costs and Future Outlook - Procurement prices for sunflower seeds have decreased compared to the same period in 2024, which is expected to benefit gross margins in 4Q25 and FY2026 [4][10]. - The company plans to enhance long-term control over core raw materials by expanding contract farming [10]. New Fiscal Year Plan - The company aims for sales revenue growth of 10%-15% for the period from July 2025 to June 2026, with specific targets for sunflower seeds and nuts [4][11]. - New product initiatives include a focus on konjac, with a target scale of RMB 50-100 million [4][11]. Channel Development - The traditional Key Account (KA) channel's contribution to sales has decreased from 40% to 35%, while the Snack Discount channel has seen rapid growth [5][12]. - Membership stores have performed well, with significant sales growth in the Hema channel [5][12].

Investment Rating - The report maintains a full-year guidance for Topsports International Holdings, targeting a net profit amount roughly flat year-on-year alongside an improvement in net profit margin [4][10]. Core Insights - In 1H FY2025, the company achieved total operating revenue of RMB 12.30 billion, a decrease of 5.8% year-on-year, with net profit attributable to owners at RMB 790 million, down 9.7% YoY [2][8]. - The gross profit margin for 1H FY2025 was 41.0%, slightly contracting by 0.1 percentage point YoY but expanding by 2.5 percentage points compared to 2H FY2024, exceeding market expectations due to brand partner subsidies [2][8]. - The company reported a significant decline in operating cash flow, down 48.2% YoY to RMB 1.35 billion, attributed to increased cash payments to suppliers and slower customer collections [3][9]. - Management indicated stable operational performance early in Q3 FY2025, with sales trends consistent with Q2, and maintained the FY2025 guidance focusing on profit-oriented strategies [4][10]. Financial Performance Summary - Total operating revenue for 1H FY2025 was RMB 12.30 billion, with retail business revenue down 3% and wholesale business revenue down 10.3% YoY [2][8]. - The effective tax rate for 1H FY2025 was 20.0%, up from 17.6% in the same period last year [2][8]. - The company declared an interim dividend of RMB 0.13 per share, with a payout ratio of 102%, slightly higher than the previous year [3][9]. Operational Trends - The total number of directly operated stores decreased by 19.4% YoY to 4,688, but the sales area per store increased by 6.5% [5][11]. - The company has built a digital matrix with over 800 Douyin accounts and over 3,600 mini-program stores, driving double-digit growth in online retail sales [5][11]. - Membership base grew to 89 million, with member sales accounting for 92.9% of total sales, indicating strong user loyalty [5][11].

Investment Rating - The report gives an "Outperform" rating for the company, indicating a positive outlook compared to the market [1][5][14]. Core Insights - The company reported stable sequential growth in Q3 2025, with revenue of 1.56 billion RMB, a year-on-year increase of 113.96%, and a net profit attributable to shareholders of 0.30 billion RMB, up 727.74% year-on-year [5][15]. - The report highlights that the company's product restructuring has led to seasonal fluctuations, with Q3 gross profit margin at 29.73%, down approximately 6.3 percentage points due to a higher revenue share from MPO products [5][15]. - The industry demand for optical modules is expected to continue growing, and the company is well-positioned as a key supplier of core materials [5][16]. Financial Summary - The company’s total revenue is projected to grow from 755 million RMB in 2023 to 4.094 billion RMB in 2027, reflecting a compound annual growth rate (CAGR) of 42.4% from 2024 to 2027 [4]. - Net profit attributable to shareholders is expected to increase significantly from -48 million RMB in 2023 to 1.047 billion RMB in 2027, with corresponding earnings per share (EPS) rising from -0.10 RMB to 2.28 RMB over the same period [4][5]. - The report sets a target price of 75.2 RMB based on a price-to-earnings (PE) ratio of 42.24x, considering the company's position and industry average valuations [5][14].

Investment Rating - The report maintains a positive outlook on Prada Group, indicating a potential for steady profit growth and resilience in its brand portfolio [5][12]. Core Insights - Prada Group reported a revenue of €4.07 billion for the first nine months of FY25, reflecting a 9% year-on-year increase at constant exchange rates, marking the 19th consecutive quarter of positive growth [1][8]. - The acquisition of Versace for an enterprise value of €1.25 billion is expected to open new growth avenues for the group [1][4]. Revenue Performance - For the first nine months of FY25, Prada brand revenue declined by 2% year-on-year, with a 1% decline in 3Q25, showing significant improvement driven by the recovery in core leather goods and ready-to-wear categories [2][9]. - Miu Miu brand revenue surged by 41% year-on-year in 9M25 and 29% in 3Q25, maintaining strong growth despite a high comparison base from the previous year [2][9]. Regional Performance - Asia-Pacific revenue increased by 10% year-on-year, with notable recovery in mainland China, while the Americas saw a 15% increase, accelerating to 20% in 3Q25 [3][10]. - Europe experienced a 6% growth, supported by stable local demand, while the Middle East recorded a 21% increase [3][10]. Strategic Initiatives - The group is focused on optimizing its retail network, enhancing customer experience, and maintaining a strong product lineup, including high-end offerings [4][11]. - The acquisition of Versace is part of a broader multi-brand strategy aimed at expanding scale and profitability over the long term [4][11]. Future Outlook - Management expresses a cautious yet optimistic view, anticipating steady profit growth supported by a premium product mix and retail efficiency gains [5][12]. - The dual-brand strategy of Prada and Miu Miu, along with the integration potential of Versace, is expected to drive growth exceeding industry averages [5][12].